The DSM-5: Implications for the Assessment and Treatment of Substance-Related Disorders | Supported by AdCare

Event Details

This training will focus on the implications of the DSM-5 regarding the assessment and treatment of Substance-Related Disorders. The Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was released at the American Psychiatric Association's Annual Meeting in May 2013.